Introduction
============

The morphogenesis and growth cycle of hair follicles (HFs), which are ectodermal accessory structures on mammalian skin, are controlled by many related signaling molecules. Along with hair growth, three processes occur during hair production: growth, cessation, and rest. In Cashmere goats, which have been used as model animals for studying the growth cycle of HFs [@B1]-[@B3], these structures are divided into primary and secondary HFs based on their temporal activities and structural characteristics. Primary HFs are responsible for the development of wool, and secondary HFs promote the development of cashmere [@B4], [@B5], which has been referred to as \"soft gold.\" Therefore, understanding the molecular mechanisms controlling the growth and development of HFs might help in improving cashmere quality and yield.

Several findings have shown that the growth and development of primary and secondary HFs are regulated by different signaling pathways [@B6], [@B7]. Researchers have found that mice with spontaneous mutations in the ectodysplasin receptor (*EDAR*) gene lacked primary HFs; however, their secondary HFs developed normally [@B8], [@B9]. This finding indicated that the growth and development of primary HFs depend on the signaling pathway comprising the tumor necrosis factor (TNF) receptor homolog, *EDAR* [@B10], [@B11]*.* The *EDAR* gene is a member of the TNF receptor superfamily [@B12]. It consists of 12 exons and encodes the EDA-A1 receptor protein, which is a type-I transmembrane protein with an extracellular cysteine-rich domain and a potential intracellular death domain. This death domain initiates intracellular signaling by interacting with adapter proteins [@B13]. In mouse and human studies, the absence of *EDAR* gene function can lead to symptoms of hypohidrotic ectodermal dysplasia (HED) [@B14]-[@B16], including dysplasia of ectodermal appendages, such as hair, teeth, and exocrine glands [@B17]. No reports have described the effects of the *EDAR* gene on HF growth in Cashmere goats. Therefore, we investigated whether the *EDAR* gene can affect the growth and development of HFs, thus affecting cashmere yield, using *EDAR*-targeted Cashmere goats.

Currently, the most common gene-editing techniques used involve the zinc finger nucleases, transcription activator-like effector nucleases, and the most recently developed clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (CRISPR-Cas9) system [@B18]. These gene-editing techniques involve engineering nucleases for cleaving a target site in a gene of interest, which, in turn, stimulates DNA repair mechanisms to complete gene modification [@B19]. In the CRISPR-Cas9 system, the target gene is recognized by single-guide RNAs (sgRNAs) that match the target gene and recognize the target in complex with the Cas9 protein [@B20]. Owing to its efficiency and advantages in terms of specificity, the CRISPR-Cas9 system has been widely used to edit genes in several species and examine gene functions in model organisms [@B21]-[@B26]. In this study, the CRISPR-Cas9 system and somatic cell nuclear transfer (SCNT) were used to obtain Cashmere goats with an *EDAR* gene mutation, providing an animal model and experimental material for studying the relationship between *EDAR* and HF growth and development. The efficiency and types of *EDAR* gene mutations in goat fibroblasts were also examined, and the comprehensive evidence of the efficiency and reliability of CRISPR-Cas9 and SCNT to generate targeted gene-modified livestock is shown.

Materials and methods
=====================

Ethics statement
----------------

All experiments performed followed the National Research Council Guide for the Care and Use of Laboratory Animals. All protocols were approved by the Institutional Animal Care and Use Committee of Inner Mongolia University. All animals were maintained at the Inner Mongolia YiWei White Cashmere Goat Limited Liability Company.

Production of sgRNAs
--------------------

Using the free tool sgRNAcas9 [@B27] to analyze the coding sequence of *EDAR*, two sgRNAs were designed for targeting exon 6: sgRNA1 (5′-GGAGAACTTCTCCGCGGGGC-3′) and sgRNA2 (5′-CGGCGCCACAAGGACTGCGA-3′). Two sets of sgRNA targeted-DNA sequences were synthesized and annealed to form double-stranded DNA, which served as templates for evaluating the sgRNAs. Using the gRNA-T2 plasmid (Viewsolid Biotech, Beijing, China), the 5′ and 3′ sequences of both sgRNAs were amplified, resulting in two fragments of 319 bp and 177 bp, respectively. These two fragments were combined with the previously annealed DNA template to obtain the complete sgRNA (455 bp) for targeting exon 6 of *EDAR*, which was inserted into the pMD-19T vector (TaKaRa Bio, Shiga, Japan) and sequenced. Plasmid DNA was purified using the EndoFree^®^ Plasmid Maxi Kit (Qiagen, Hilden, Germany), according to the manufacturer\'s instructions.

Cell culture and transfection
-----------------------------

Inner Mongolia Cashmere goat fetal fibroblasts (GFbs) were cultured in Dulbecco\'s modified Eagle\'s medium/F12 containing 10% fetal bovine serum in 5% CO~2~ at 37ºC. The sgRNA and Cas9 plasmids (Viewsolid Biotech) were transfected into the GFbs by electroporation at 225 v/2.5 ms, as previously described [@B28].

Clonal cell line screening
--------------------------

Twenty-four hours after transfection, the GFbs were digested in suspension with trypsin, diluted to 1 cell/100 µl, and seeded into 96-well cell culture plates for expansion. With each clonal cell line, half of the expanded cells were used to extract genomic DNA (gDNA) to identify the *EDAR* gene mutation, and the other half was cultured for use in further experiments. The *EDAR* mutant cell lines were confirmed by comparing the target sequences of wild-type cells and the clonal cell lines. Target sequence fragments were amplified by polymerase chain reaction (PCR) using the following primers: 5′-GTGGTGGTCGTCGTGGTGATGC-3′ and 5′-CTGCTCAGCCTTCCTTATGGTC-3′. The PCR conditions used were as follows: 94°C for 10 min; 35 cycles of 94°C for 30 s, 63°C for 45 s, and 72°C for 1 min; and 72°C for 10 min.

Preparation and transplantation of cloned embryos
-------------------------------------------------

The preparation and transplantation of cloned embryos were performed as previously described [@B29]. An *EDAR* mutant cell line was used as a donor in the preparation of the clonal Cashmere goat embryos. Oocytes used for SCNT were isolated from goat ovaries collected at a local slaughterhouse and cultured by in vitro maturation for 18 to 20 h. A single targeted GFb cell was transplanted into individual enucleated oocytes by microscopic manipulation, and the cytoplasmic membranes of the donor and recipient cells were then fused and activated to form reconstructed embryos. Finally, these embryos were cultured in an embryonic development medium at 38.5°C for 48 to 50 h. When the embryos had reached the two-to-eight-cell stage, they were transplanted into the oviduct of recipient Cashmere does.

Surveyor nuclease mutation-detection assay
------------------------------------------

Wild-type Alba white Cashmere GFbs were obtained and used as controls. These GFbs were transfected by electroporation, either with the sgRNA1 and Cas9 plasmids, or the sgRNA2 and Cas9 plasmids. At 48 h post-transfection, the gDNAs of the modified and wild-type cells were extracted using the cell genome extraction kit (TianGen Biotech, Beijing, China). These gDNAs were then used as templates to amplify the target sequence of the *EDAR* gene via PCR with the following primers 5′-GTGGTGGTCGTCGTGGTGATGC-3′ (forward) and 5′-CTGCTCAGCCTTCCTTATGGTC-3′ (reverse). The PCR conditions used were as described above. The resulting amplicons were purified and mixed with 10× La PCR Buffer II (TaKaRa Bio, Shiga, Japan), and a heteroduplex was formed by gradient annealing under the following conditions: 95°C for 10 min, 95 to 85°C ramping at -2°C/s, 85 to 25°C at -0.3°C/s, and a 4°C hold. The heteroduplexes were processed using the Surveyor Mutation Detection Kit (Transgenomic, Omaha, NE, USA) and run on a 2% agarose gel to detect mutation efficiency.

Western blot analysis
---------------------

Expression of the *EDAR* gene in the skin samples of the *EDAR* gene-targeted Cashmere goats was detected by western blot analysis. Total protein was extracted from skin samples obtained from the head, back, and body side of the *EDAR* gene-targeted goats; separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis; and transferred to a nitrocellulose membrane. This membrane was blocked with 5% skimmed milk at room temperature for 1 h and incubated overnight at 4°C using an anti-*EDAR* antibody (1: 1,000 dilution) and an anti-β-actin antibody (1: 10,000 dilution) as a loading control. After incubation, the membrane was rinsed sequentially with phosphate-buffered saline and phosphate-buffered saline containing 0.05% Tween-20 solution. Subsequently, the membrane was treated with a secondary goat anti-rabbit antibody. Protein bands were visualized using the Tanon-5200 image-analysis system (Tanon Science & Technology Co., Ltd).

Skin tissue sections
--------------------

Skin samples from the head, back, and body side of the *EDAR* gene-targeted Cashmere goats were fixed in 4% paraformaldehyde for 24 h, dehydrated using an alcohol-xylene series, and embedded in paraffin wax. Sample blocks were then cut into 5-µm sections using a microtome and routinely stained with hematoxylin and eosin. The growth and development of the HFs were analyzed by observing skin cross-sections under a microscope.

Off-target analysis
-------------------

Potential off-target genome-editing sites (Table [S1](#SM0){ref-type="supplementary-material"}) were predicted using the free tool sgRNAcas9 [@B27]. Flanking sequences at each site were extracted, and the DNA sequence of each potential off-target site was amplified using the gDNA of wild-type and *EDAR* gene-targeted Cashmere goats as templates and the primers listed in Table [S2](#SM0){ref-type="supplementary-material"}. Variants were identified by multiple sequence alignments.

Statistical methods
-------------------

Data are presented as the mean ± standard deviation. Significant differences were evaluated by performing student\'s *t* tests, and *P* \< 0.05 was considered as the threshold for statistical significance.

Results
=======

Efficiency of the CRISPR-Cas9 system in GFbs
--------------------------------------------

The specific target information for both opposite sgRNAs designed to remove *EDAR* gene function is shown in Figure [1](#F1){ref-type="fig"}A. To determine their cutting efficiencies, the sgRNA1, sgRNA2, and Cas9 plasmids were transfected into GFbs, and their gDNA was extracted at 48 h post-transfection. The target sequence was amplified by PCR and then analyzed using Surveyor nuclease to detect mutations. Mutations occurred in both samples in different degrees, indicating that both sgRNAs could be used in *EDAR* gene-targeting experiments (Figure [1](#F1){ref-type="fig"}B).

Mutation of the *EDAR* gene in clonal cell lines
------------------------------------------------

Both the sgRNA plasmids and Cas9 plasmid were transfected into GFbs to establish 89 different *EDAR* gene-targeted cell lines, which were developed by culturing individual clones. The gDNA of each clonal cell line was extracted and the target sequence of the *EDAR* gene was obtained. Multiple sequence alignment revealed nine types of mutations (Figure [1](#F1){ref-type="fig"}D), and 62 cell lines presented mutations in the target region (Figure [2](#F2){ref-type="fig"}). Thus, the gene-targeting efficiency was 69.7%. The monoallelic mutation rate was 37.1% and the biallelic mutation rate was 32.6% (Table [1](#T1){ref-type="table"}). Cell line 5069 grew well, showed a type-II mutation pattern (Figure [1](#F1){ref-type="fig"}C, 1D), and harbored a large deletion mutation in the targeted region of the *EDAR* gene. Therefore, this cell line was used as the donor to prepare cloned *EDAR* gene-mutant embryos.

Cloned *EDAR* gene-targeted Cashmere goats
------------------------------------------

Wild-type and *EDAR* gene-targeted positive cells were used as nuclear donor cells. Regarding the use of wild-type cells, only 761 mature oocytes were obtained during in vitro culture of the 1,227 oocytes collected from the Cashmere goats. Among the 751 embryos that were successfully cloned, 545 embryos were fused and 542 were activated, finally resulting in 340 dividing embryos comprising 121 2-cell embryos, 160 4-cell embryos, and 59 8-cell embryos (Table [2](#T2){ref-type="table"}). To construct cloned embryos from the *EDAR* gene-targeted positive cells, 3,339 oocytes were collected, and 1,875 mature oocytes were obtained in vitro. Among the 1,853 cloned embryos that were successfully prepared, 1,557 were fused and 1,543 were activated, finally resulting in 866 dividing embryos comprising 329 2-cell embryos, 430 4-cell embryos, and 107 8-cell embryos (Table [2](#T2){ref-type="table"}). Comparison of the developmental stages of the embryos revealed that the fusion rate of the *EDAR* gene-targeted cloned embryos was significantly higher than that of the wild-type embryos (Figure [3](#F3){ref-type="fig"}B), but no significant difference was observed at other stages. Although 79 recipient goat embryo-transfer surgeries were performed (Table [S3](#SM0){ref-type="supplementary-material"}), only five resulted in pregnancy and the conception rate was 6.3%. After a gestation period of five months, six male goats were born--- two stillbirths and four live goats; two of the live goats survived for only 20 h. The other two goats grew normally (Table [3](#T3){ref-type="table"}), presenting the characteristic lack of hair on the top of their heads (Figure [4](#F4){ref-type="fig"}A).

Characterization of *EDAR* gene-targeted Cashmere goat
------------------------------------------------------

None of the newborn *EDAR* gene-targeted Cashmere goats had hairs on the top of their heads (Figure [4](#F4){ref-type="fig"}A). Histological analysis revealed that no HFs were present in the skin of the head, but back and body side skin samples had primary HFs of differing diameters randomly distributed near secondary HFs. This pattern differed from that of the wild-type samples, where three primary HFs were distributed along the side of the secondary HF clusters. However, the arrangement pattern of the secondary HFs was not significantly different between the wild-type and *EDAR* gene-targeted samples (Figure [4](#F4){ref-type="fig"}B). In addition, most HFs in the skin samples of the wild-type goats had a diameter of approximately 30 μm, whereas, most HFs in the skin samples of the *EDAR* gene-targeted goats had a diameter of approximately 20 μm. HFs larger than 50 μm were more frequent in the *EDAR* gene-targeted Cashmere goats than in the wild-type goats (Figure [5](#F5){ref-type="fig"}B). We could not detect EDAR protein expression by western blot analysis in the head, body, and back skin samples of the *EDAR* gene-targeted Cashmere goats (Figure [5](#F5){ref-type="fig"}A), indicating that *EDAR* was correctly silenced in these individuals.

Off-target analysis
-------------------

Although the CRISPR-Cas9 system shows high efficiency in gene editing, off-target mutations can occur. To detect off-target mutations in the *EDAR* gene-targeted goats, gDNA sequences compatible with sgRNA1 and sgRNA2 were examined, and 43 potential off-target sites were selected, amplified, sequenced, and analyzed. Although no off-target mutations were found, it is uncertain whether they occurred at untested sites.

Discussion
==========

The high gene-editing efficiency of the CRISPR-Cas9 system has been confirmed in numerous studies. In this study, the gene-targeting efficiency of the CRISPR-Cas9 system in the GFbs was 69.7%, with a single-allelic mutation rate of 37.1% and a double-allelic mutation rate of 32.6%. To ensure the successful establishment of the *EDAR* gene-targeted Cashmere goats, two opposite sgRNAs were first designed to improve the targeting efficiency and promote a large fragment deletion. This improvement was confirmed experimentally. SCNT was also key to the success of the experiments performed in this study, as we decided not to inject the Cas9 mRNA and sgRNAs into fertilized eggs. Instead, we selected gene-targeted positive cells as nuclear donor cells and prepared the *EDAR* gene-targeted Cashmere goats by SCNT. This approach resulted in a low birth rate, but enabled a very high degree of gene editing that avoided uncertainty in the cloned Cashmere goat genotypes and provided a solid basis for subsequent experiments.

By comparing the developmental stages of embryos, we found that the fusion rate of the *EDAR* gene-targeted cloned embryos was significantly higher than that of the wild-type embryos (Figure [3](#F3){ref-type="fig"}B), but no significant difference was observed at other stages. Because the *EDAR* gene-targeted positive cells have a larger diameter than the wild-type cells, these donor cell membranes have a larger area of contact with the oocyte\'s cellular membrane during somatic cell-cloning procedures, thus helping to reconstitute the cell membranes of embryos (i.e., fusion), thereby improving the fusion rate of the cloned *EDAR* gene-targeted embryos.

The*EDAR* gene-targeted Cashmere goats produced through CRISPR-Cas9-based gene editing followed by SCNT had no hair on the top of their heads (Figure [4](#F4){ref-type="fig"}A), and EDAR protein expression was not detected in their head skin tissues (Figure [5](#F5){ref-type="fig"}A). In addition, no HFs were found in the head skin samples of these goats, although the back and body skin samples presented primary HFs of different diameters randomly distributed around secondary HFs. This distribution was distinct from that found in the wild-type goats, where three primary HFs were distributed along the side of the secondary HF clusters. However, secondary HFs did not differ significantly between the *EDAR* gene-targeted and wild-type goats (Figure [4](#F4){ref-type="fig"}B). These findings agree with the results of a mouse *EDAR* gene-mutation study, which revealed that the *EDAR* gene affected the growth of primary HFs, but had no effect on secondary HFs [@B30]. Although the *EDAR* gene-targeted Cashmere goats provide a valuable animal model for future studies on the *EDAR* gene-related phenotypes, and HF growth and development, this model has some limitations, including the presence of sparse hair and dry skin, and the lack of sweat glands. Thus, the model faces an adaptability challenge. Because HFs first appear during the embryonic period [@B31], [@B32], it is necessary to study their growth and development from this stage, and the animal model presented here enables such evaluation.

Although the experiments of the present study established the founders of *EDAR* gene-targeted Cashmere goats, the animals have not reached sexual maturity or produced an F1 generation. Providing a suitable environment for these founders is particularly important for maintaining their health. Previous data have shown that abnormal epigenetic modifications might affect the phenotype of clonal animals produced by somatic cloning techniques [@B33], but such effects of epigenetic modifications are presently unknown for the *EDAR* gene-targeted Cashmere goats reported here. Epigenetic modifications can only be confirmed when the F1 generation is born.

Although no off-target mutations were found among the 43 potential off-target sites in the *EDAR* gene-targeted Cashmere goats, this finding does not confirm the lack of off-target mutations. The goat genome is not yet complete, and this limitation affected our search for potential off-targets in the genome. In addition, some clonal cell lines did not grow normally and could not be selected as donor cells for SCNT, which might reflect off-target mutations occurring in those cell lines.

In conclusion, the CRISPR-Cas9 system and SCNT can be used for gene editing in Cashmere goats. The *EDAR* gene-targeted Cashmere goats have abnormal primary HFs and no hair on the top of their heads. The findings of the present study provide a basis for studying gene editing in large mammals, as well as an animal model for studying *EDAR* gene functions in terms of HF growth and development.
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![**CRISPR-Cas9 system mediates *EDAR* gene targeting in GFbs.** (a) Schematic representation of sgRNAs targeting exon 6 of the *EDAR* gene. The red letters represent the target sequence of each sgRNA. The blue letters indicate the PAM sequence. (b) Surveyor nuclease mutation-detection assay. Lanes 1 and 2: PCR products of the GFbs transfected with sgRNA1 + Cas9 or sgRNA2 + Cas9 plasmids, following treatment with Surveyor nuclease. Lanes 3 and 4: positive experimental group and negative experimental control group, respectively. M lane: 200-bp DNA Ladder Marker. (C) Cell line positive for a targeted *EDAR* gene mutation. (d) Nine different types of mutations occurred in the cell lines with *EDAR* gene mutations. The dotted line in the diagram represents the missing base fragment. The red box represents the inserted fragment. The red line at the top indicates the position of the sgRNA. WT, wild type](ijbsv14p0427g001){#F1}

![**The *EDAR* gene-mutation genotype in the clonal cell lines.** Green box: monoallelic mutation. Orange box: biallelic mutation](ijbsv14p0427g002){#F2}

![***EDAR* gene-targeted cloned embryos.** (A) The *EDAR* gene-targeted cloned embryos at various developmental stages. Scale bar = 100 μm. (B) Ratio of the cloned embryos at various developmental stages. Red indicates the *EDAR* gene-targeting cloned embryos and blue indicates the wild-type cloned embryos. (\*\*\* p \<0.001)](ijbsv14p0427g003){#F3}

![***EDAR* gene-targeted Cashmere goats and skin tissue sections.** (A) *EDAR* gene-targeted Cashmere goats. The left photo shows two surviving *EDAR* gene-targeted Cashmere goats, which displayed the characteristic hairlessness on their heads. The right panel shows a comparison of the *EDAR* gene-targeted Cashmere goats with the wild-type Cashmere goats. (B) Cross-sectional and longitudinal-section images of cutaneous tissues from different body parts of the *EDAR* gene-targeted Cashmere goats and wild-type Cashmere goats. Scale bar = 100 μm.](ijbsv14p0427g004){#F4}

![**Western blotting and HF distribution.** (A) No *EDAR* gene expression was detected in the head, back, and body of the *EDAR* gene-targeted Cashmere goats. (B) Distribution of HFs in the skin of the *EDAR* gene-targeted Cashmere goats.](ijbsv14p0427g005){#F5}

###### 

*EDAR* gene targeting in the GFbs using the CRISPR-Cas9 system

  Monoallelic mutation   Biallelic mutation   Mutation-positive
  ---------------------- -------------------- -------------------
  33/89 (37.1%)          29/89 (32.6%)        62/89 (69.7%)

###### 

Preparation of clonal embryos with *EDAR* gene mutations

  Type        Oocytes   Mature oocytes   Cloned embryos   Fused embryos   Activated embryos   Embryo type         
  ----------- --------- ---------------- ---------------- --------------- ------------------- ------------- ----- -----
  EDAR^-/-^   3,339     1,875            1,853            1,557           1,543               392           430   107
  WT          1,227     761              751              545             542                 121           160   59

###### 

The birth of *EDAR*-mutant Cashmere goats

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Recipient goat number   Date of lambing   *EDAR* mutant goat number   Lamb sex   Birth weight of lamb   Survival status   Phenotype
  ----------------------- ----------------- --------------------------- ---------- ---------------------- ----------------- ---------------------
  404338                  9-Mar-17          1701                        ♂          2.82 kg                Survived\         No hair on the head
                                                                                                          24 h              

  916051                  11-Mar-17         1702                        ♂          2.69 kg                Survived\         No hair on the head
                                                                                                          20 h              

  916051                  11-Mar-17         1703                        ♂          3.8 kg                 Died              No hair on the head

  913006                  14-Mar-17         1704                        ♂          5.2 kg                 Died              No hair on the head

  922009                  17-Mar-17         1705                        ♂          3.3 kg                 Currently alive   No hair on the head

  118140                  19-Mar-17         1706                        ♂          5.35 kg                Currently alive   No hair on the head
  -----------------------------------------------------------------------------------------------------------------------------------------------
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